ibutilide has been researched along with Tachycardia, Ventricular in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, LV; Cimini, MG; Clark, MA; Emmert, DE; Gibson, JK; Glavanovich, MA; Hester, JB; Imbordino, RJ; LeMay, RJ; McMillan, MW; Perricone, SC; Squires, DM; Walters, RR | 1 |
| Gonzalez, MD; Sendra-Ferrer, M | 1 |
| Havakuk, O; Viskin, S | 1 |
| Crijns, HJ; Vos, MA | 1 |
| Khan, MH | 1 |
| Ellenbogen, KA; Meissner, MC; Perry, KT; Sager, PT; Stambler, BS; Vanderlugt, JT; Wakefield, LK; Wesley, RC; Wood, MA; Zoble, RG | 1 |
| Ellenbogen, KA; Perry, KT; Stambler, BS; VanderLugt, JT; Wakefield, LK; Wood, MA | 1 |
| Ellenbogen, KA; Gilligan, DM; Perry, KT; Stambler, BS; VanderLugt, JT; Wakefield, LK; Wood, MA | 1 |
| Goyal, R; Knight, BP; Michaud, GF; Morady, F; Oral, H; Souza, JJ; Strickberger, SA | 1 |
| Ahern, T; Denker, S; Kowey, PR; Mattioni, T; Perry, KT; Torchiana, D; VanderLugt, JT; Wakefield, LK | 1 |
| Chugh, SS; Johnson, SB; Packer, DL | 1 |
| Brown-Mahoney, C; Ellenbogen, KA; Gilligan, DM; Nematzadeh, F; Stambler, BS; Wood, MA | 1 |
3 review(s) available for ibutilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disease Models, Animal; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Drug Interactions; Electrocardiography; Female; Humans; Male; Polypharmacy; Retrospective Studies; Sulfonamides; Tachycardia, Ventricular | 2002 |
5 trial(s) available for ibutilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Time Factors | 1996 |
Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Forecasting; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome | 1996 |
Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide Investigators.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Humans; Refractory Period, Electrophysiological; Stroke Volume; Sulfonamides; Tachycardia, Ventricular | 1998 |
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Premedication; Secondary Prevention; Sulfonamides; Tachycardia, Ventricular | 1999 |
Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Postoperative Complications; Sulfonamides; Tachycardia, Ventricular | 1999 |
4 other study(ies) available for ibutilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Dogs; Humans; In Vitro Techniques; Male; Microsomes, Liver; Rabbits; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Tachycardia, Ventricular | 2001 |
Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability.
Topics: Administration, Intravenous; Aged; Anti-Arrhythmia Agents; Electric Countershock; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Sulfonamides; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2019 |
Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
Topics: Brugada Syndrome; Electrocardiography; Exercise Test; Humans; Long QT Syndrome; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2016 |
Altered response to ibutilide in a heart failure model.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Sulfonamides; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2001 |